Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2021 Mar;32(3):298-308. doi: 10.1016/j.annonc.2020.11.008. Epub 2020 Nov 26.

¹ Department of Medicine III, LMU Hospital Munich, Germany.
² Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
³ Haematology, Peninsula School of Medicine, Plymouth, UK.
⁴ Service d'Hématologie, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Lyon; Université Claude Bernard Lyon-1, Pierre-Benite, France.
⁵ Divisione di Ematologia, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
⁶ Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
⁷ Department of Radiation Oncology, University of Heidelberg, Germany.
⁸ Department of Haematology, Peter McCallum Cancer Center & Royal Melbourne Hospital, Melbourne, University of Melbourne, Parkville, Australia.
⁹ Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden.

No abstract available

Keywords: antibody; chemotherapy; follicular lymphoma; lenalidomide; radiotherapy.

Publication types